A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody <scp>MK</scp> ‐1654 in healthy Japanese adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK ‐1654 in healthy Japanese adults

Published:2022-05-17 Issue:7 Volume:15 Page:1753-1763
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Orito Yuji¹,Otani Naoyuki²,Matsumoto Yuki¹,Fujimoto Katsukuni¹,Oshima Nobuyuki¹,Maas Brian M.³,Caro Luzelena³,Aliprantis Antonios O.³⁴,Cox Kara S.³,Tokumaru Osamu²,Kodama Masaaki²,Kudo Hideo²,Imai Hiromitsu²^ORCID,Uemura Naoto²

Affiliation:

1. MSD K.K. Tokyo Japan

2. Oita University Oita Japan

3. Merck and Co., Inc. Rahway New Jersey USA

4. Flagship Pioneering Boston Massachusetts USA

Funder

Merck

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13290

Reference28 articles.

1. Epidemic dynamics of respiratory syncytial virus in current and future climates

2. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

3. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000

4. The Burden of Respiratory Syncytial Virus Infection in Young Children

5. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development;Reviews in Medical Virology;2024-08-29

2. A molecular perspective for the development of antibodies against the human respiratory syncytial virus;Antiviral Research;2024-02

3. Clinical research on RSV prevention in children and pregnant women: progress and perspectives;Frontiers in Immunology;2024-01-24

4. Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments;Clinical Microbiology and Infection;2023-12

5. The road to approved vaccines for respiratory syncytial virus;npj Vaccines;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3